In an analysis on Vigibase of ICI case reports from global WHO data, Wei et al. (46) reported that combination blockade against CTLA-4 and PD-1/PD-L1 had an increased rate of myocarditis than monotherapy alone (1.22% vs. 0.54%). The gene discussed is CD274; the disease is myocarditis.